Silverarc Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-443,381
| Closed | -$14.2K | – | 86 |
|
|
2022
Q1 | $14.2K | Buy |
443,381
+251,336
| +131% | +$8.06K | 5.88% | 3 |
|
|
2021
Q4 | $4.18M | Buy |
192,045
+28,559
| +17% | +$621K | 1.69% | 17 |
|
|
2021
Q3 | $3.58M | Buy |
163,486
+24,181
| +17% | +$530K | 2.03% | 17 |
|
|
2021
Q2 | $2.71K | Buy |
139,305
+4,624
| +3% | +$90 | 1.21% | 27 |
|
|
2021
Q1 | $2.32M | Sell |
134,681
-319
| -0.2% | -$5.5K | 1.27% | 30 |
|
|
2020
Q4 | $2.16M | Buy |
+135,000
| New | +$2.16M | 1.26% | 31 |
|